Shinde Lab at the University of South Florida in Tampa, Florida, invites applications for multiple Postdoc positions supported by #NCI funding. #USF#Microbiome
Postdoctoral Fellow — Microbiome, Immunity & Cancer Shinde Lab | Microbiomes Institute | USF https://t.co/x4qTsEn4Il
Great preview of our work just came out @Cell_Metabolism Absolutely gratifying! #PancreaticCancer
@ShindeLabWistar @TheWistar@SciImmunology
Microbiome-derived metabolites counteract tumor-induced immunosuppression and boost immune checkpoint blockade https://t.co/m84bQpbrel
New research in mice, supported in humans, spotlight the gut microbiome’s vast and largely unexploited potential to be harnessed in clinical settings. @TheWistar @ShindeLabWistar
https://t.co/6M6fpge3Yv
Gut microbial metabolite, TMAO could help amplify immune checkpoint blockade (ICB) success rates in resistant cancers, such as pancreatic #cancer, suggests a new study from @TheWistar @ShindeLabWistar.
https://t.co/6M6fpgdw8X
In a paper published in @SciImmunology, @TheWistar’s Dr. Rahul Shinde shows a gut microbe metabolite boosts antitumor immunity in #PancreaticCancer. https://t.co/0Sw5mSDtUh
Happy to share our @ShindeLabWistar research findings @SciImmunology describing the anti-tumor immune effects of a gut microbe-derived metabolite, TMAO, in pancreatic cancer. #PancreaticCancer#microbiota#Immunotherapy https://t.co/wazpd2qsHN
New study from @UHN's Dr. Tracy McGaha shows that body’s system for removing dead cells could be new therapeutic target for #lupus and #cancer https://t.co/WwtIFd0AxB